Talk:Mesalazine
From Wikipedia, the free encyclopedia
 |
This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess. |
| Start | This page has been rated as start-Class on the quality assessment scale |
| Mid | This article has been rated as Mid-importance on the importance assessment scale |
 |
Mesalazine is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. |
| Start | This article has been rated as start-Class on the quality scale. |
| Mid | This article has been rated as mid-importance for this Project's importance scale. |
|
|
|
"Methaeoglobinaemia" is listed as a side effect. Should this be "Methaemoglobinaemia" (with an "m"), which redirects to Methemoglobinemia? Songdog 15:13, 8 March 2006 (UTC)
Content moved from mesalamine to mesalazine to reflect the International Nonproprietary Name rather than the United States Approved Name PeteThePill 22:55, 18 Jun 2005 (UTC)
shouldnt there be a specific articel about what 2 hydroxybenzoi cacid
[edit] Lialda
The section describing Lialda sounds a little bit like a sales pitch for the drug. The other formulations are not really mentioned much, and it seems to be emphasizing benefits of Lialda that don't seem proven yet. I'm just a layperson when it comes to this stuff, so please take my comment with a grain of salt. —Preceding unsigned comment added by 198.135.207.129 (talk) 16:19, 17 January 2008 (UTC)
